Issue: 2003 > June > review

Platelet aggregation inhibitors in prevention and treatment of coronary thrombosis

M.E.R. Gomes, F.W.A. Verheugt


Platelet aggregation plays a key role in the development of complications of atherosclerosis. By inhibiting platelet aggregation in a pharmacological way complications such as myocardial infarction and sudden death may be prevented. This goes for primary as well as secondary prevention. The most relevant substances for this goal are aspirin, clopidogrel and the new glycoprotein IIb/IIIa inhibitors.